Published in Rejuvenation Res on December 01, 2007
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nat Clin Pract Cardiovasc Med (2009) 1.31
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. Am J Ophthalmol (2011) 0.93
Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiol Aging (2012) 0.92
Lipoprotein (a): impact by ethnicity and environmental and medical conditions. J Lipid Res (2015) 0.81
Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery. Br J Pharmacol (2016) 0.78
Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients. Age (Dordr) (2010) 0.77
Computationally Modeling Lipid Metabolism and Aging: A Mini-review. Comput Struct Biotechnol J (2014) 0.77
Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients. Rejuvenation Res (2009) 0.76
Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases. Front Pharmacol (2016) 0.75
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients. Age (Dordr) (2010) 0.75
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol (2007) 4.03
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology (2007) 2.32
Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry (2010) 2.22
An association study between epicardial fat thickness and cognitive impairment in the elderly. Am J Physiol Heart Circ Physiol (2014) 2.06
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease. J Am Geriatr Soc (2008) 2.05
The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol (2008) 1.64
Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry (2005) 1.63
Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res (2008) 1.60
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res (2004) 1.55
Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging (2005) 1.46
Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol (2003) 1.45
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease. Intern Emerg Med (2011) 1.42
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial. Phys Ther (2009) 1.35
From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol (2012) 1.33
Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf (2008) 1.31
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev (2010) 1.30
Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol (2007) 1.28
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis (2010) 1.23
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy (2012) 1.18
The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimers Dis (2009) 1.16
Diverticular disease in the elderly. Dig Dis (2007) 1.11
Fatal systemic venous air embolism during endoscopic retrograde cholangiopancreatography. Adv Anat Pathol (2009) 1.08
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry (2012) 1.08
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimers Dis (2010) 1.06
Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp Gerontol (2005) 1.06
Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother (2008) 1.06
Marital and cohabitation status as predictors of mortality: a 10-year follow-up of an Italian elderly cohort. Soc Sci Med (2008) 1.05
Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. Prog Lipid Res (2011) 1.05
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? Expert Opin Investig Drugs (2011) 1.04
Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett (2003) 1.04
Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother (2011) 1.03
Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta (2005) 1.03
Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging (2009) 1.02
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter (2007) 1.01
A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients. Genes Chromosomes Cancer (2007) 1.01
Focus on acute diarrhoeal disease. World J Gastroenterol (2009) 1.01
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging (2011) 1.00
Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev (2008) 1.00
Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging (2005) 0.99
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? Front Aging Neurosci (2010) 0.98
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease. Ageing Res Rev (2009) 0.98
Lipid metabolism in cognitive decline and dementia. Brain Res Rev (2006) 0.98